UnitedHealth Group reported stronger-than-expected Q3 results and raised its full-year earnings guidance, reflecting solid growth and effective cost management. Positive contributions from the Optum segment and optimistic management tone suggest investor confidence. The stock is likely to experience a positive impact in the next 1â€“2 weeks.

[1]